Tech Company Financing Transactions
HTG Molecular Diagnostics Funding Round
HTG Molecular Diagnostics, based in Tucson, received $3.4 million from Solstice Capital, Desert Angels and Emerging Technology Partners.
Transaction Overview
Company Name
Announced On
6/8/2005
Transaction Type
Venture Equity
Amount
$3,400,000
Round
Series B
Investors
Solstice Capital (Lead Investor) (Harry George)
Proceeds Purpose
HTG will use the funds to further expand manufacturing, sales and marketing activities as well as to hire additional personnel and increase product trials in support of its patented ArrayPlate qNPA technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3430 East Global Loop
Tucson, AZ 85706
USA
Tucson, AZ 85706
USA
Phone
Website
Email Address
Overview
Headquartered in Tucson, Arizona, HTG Molecular Diagnostics' mission is to empower precision medicine at the local level.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Timothy Johnson
Chief Executive Officer
John Lubniewski
VP - Finance
Shaun McMeans
VP - Regulatory Affairs
Sam Rua
Browse more venture capital transactions:
Prev: 6/8/2005: Synovis Orthopedic and Woundcare venture capital transaction
Next: 6/9/2005: Pixim venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs